Vol. 4 — July-August 2008

• Primary aldosteronism - Part I: prevalence, screening, and selection of cases for adrenal vein sampling
  

  G.P. Rossi¹, T.M. Seccia, A.C. Pessina

  (1) Department of Clinical and Experimental Medicine, Clinica Medica 4, University of Padua, Padua – Ita

• Primary aldosteronism: Part II: subtype differentiation and treatment
  

  G.P. Rossi¹, T.M. Seccia, A.C. Pessina

  (1) Department of Clinical and Experimental Medicine, Clinica Medica 4, University of Padua, Padua – Ita

• IgA nephropathy: lessons from an animal model, the ddY mouse
  

  Yasuhiko Tomino

• Magnetic resonance imaging: advances in the investigation of atheromatous renovascular disease
  

  C. Chrysochou¹, D.L. Buckley, P.A. Kalra

  (1) Renal Department, Salford Royal Hospital NHS Foundation Trust, Salford, Manchester - UK

• Hemoglobin normalization trials in chronic kidney disease: what should we learn about quality of life as an end point?
  

  Adrian Covic¹, A. Seica², Paul Gusbeth-Tatomir², David Goldsmith³

  (1) Nephrology Clinic, 'Dr. C. I. Parhon' University Hospital, Iasi - Romania
  (2) Nephrology Clinic, “Dr. C. I. Parhon” University Hospital, Iasi
  (3) Renal Unit, Guy's Hospital, London - UK

• Regulatory T cells and transplantation tolerance
  

  S.P. Cobbold¹

  (1) Sir William Dunn School of Pathology, University of Oxford, Oxford – UK

• Recombinant human erythropoietins, biosimilars and immunogenicity
  

  Huub Schellekens¹

  (1) Department of Innovation Studies, Central Laboratory Animal Institute, Utrecht University, Utrecht -

• Pharmacogenetics of mycophenolate mofetil: a promising different approach to tailoring immunosuppression?
  

  G.N. Betonico¹, M. Abudd-Filho, E.M. Goloni-Bertollo, E. Pavarino-Bertelli

  (1) Genetics and Molecular Biology Research Unit – UPGEM, Sao Jose' do Rio Preto Medical School (FAMERP)

• Treatment of reduced bone density with ibandronate in dialysis patients
  

  R. Bergner¹, D. Henrich, M. Hoffmann, H. Schmidt-Gayk, T. Lenz, M. Upperkamp

  (1) Medizinische Klinik A, Klinikum der Stadt Ludwigshafen GmbH, Ludwigshafen am Rhein - Germany

• Clinical and pathological study of Kimura’s disease with renal involvement
  

  Chunbei Liu, Weixin Hu, Huiping Chen, Zheng Tang, Caihong Zeng, Zhihong Liu, Leishi Li

• Renal failure is a risk factor for cefepime-induced encephalopathy
  

  E. O. Garces, Mauro F. Andrade de Anzambuja, D. da Silva, J.A.. Bragatti, T. Jacoby, Fernando S. Thome'

• Prediction of subclinical renal allograft rejection by vascular endothelial growth factor in serum and urine
  

  W. Peng, J. Chen, Y. Jiang, Z. Shou, Y. Chen, Hong Wang

• Epoetin alfa and darbepoetin alfa: effects on ventricular hypertrophy in patients with chronic kidney disease
  

  H.-H. Chen¹, D.-C. Tarng, K.-F. Lee, C.-J. Wu, Y.-C. Chen

  (1) Division of Nephrology, Department of Medicine, Mackay Memorial Hospital, Taipei and Mackay Medicin

• Physical functioning in patients with chronic kidney disease
  

  J. Padilla, J. Krasnoff, M. DaSilva, C.-Y. Hsu, L. Frassetto, K.L. Johansen, P. Painter

• Effective treatment administration of cyclophosphamide in membranous nephropathy
  

  F. Dede, D. Ayli, S. Sahiner

• Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients with left ventricular
  

  H. Ibsen¹, M.H. Olsen, K. Wachtell, K. Borch-Johnsen, L.H. Lindholm, C.E. Mogensen

  (1) Department of Cardiology, Holbaek Hospital, Holbaek - Denmark

• Sex-based differences in lupus nephritis: a study of 235 Indian patients
  

  S.S. Soni, S. Gowrishankar, G.K. Adikey, A. Raman

• Efficacy of deferoxamine, N-acetylcysteine and selenium treatments in rats with Adriamycin-induced nephrotic syndrome
  

  F. Bulucu¹, C. Oktenli, L. Kenar, R. Ocal, B. Koc, V. Inal, L. Yamanel, H. Yaman, Y.S. Sanisoglu, A. Aydin

  (1) Department of Internal Medicine, Gulhane Military Medical Academy, Ankara - Turkey

• Early initiation of tacrolimus or cyclophosphamide therapy for idiopathic membranous nephropathy with severe proteinuria
  

  Xiayu Li, Rong Lv, Qiang He, Heng Li, Xiaoying Du, Weiqin Lin, Qun Li, Xuelin He, Suya Wang, Jianghua Chen

• ORAMA: a study to investigate EBPG impact on renal anaemia – design and baseline data
  

  Francesco Locatelli¹, Adrian Covic², Iain C. Macdougall³, Andrzej Wiecek⁴, On behalf of the ORAMA Study Grou

  (1) Division of Nephrology and Dialysis, “A. Manzoni” Hospital, Lecco - Italy
  (2) Nephrology Clinic, 'Dr. C. I. Parhon' University Hospital, Iasi - Romania
  (3) Renal Unit, King’s College Hospital, London - UK
  (4) Department of Nephrology, Endocrinology and Metabolic Diseases, Silesian Medical University, Katowic

• High-dose calcitriol therapy and progression of cardiac vascular calcifications
  

  M. Morosetti¹, L. Jankovic, G. Palombo, S. Cipriani, S. Dominijanni, A. Balducci, G. Splendiani, G. Simonetti, A. Romagnoli, Giorgio Coen

  (1) Nephrology and Dialysis Department, 'G.B. Grassi' Hospital - Ostia Lido, Rome - Italy

• Severe renal complications in chronic myelomonocytic leukemia
  

  R. Enriquez, A.E. Sirvent, F. Marin, M. Perez, M.R. Alpera, F. Amords

• Subacute renal failure in diabetic nephropathy due to endocapillary glomerulonephritis and cholesterol embolization
  

  F. Rivera, C. Vozmediano, L. Gonzalez-Lopez, A. Carreno, J. Blanco